JP2008002974A - Covering body and using method of covering body - Google Patents
Covering body and using method of covering body Download PDFInfo
- Publication number
- JP2008002974A JP2008002974A JP2006173246A JP2006173246A JP2008002974A JP 2008002974 A JP2008002974 A JP 2008002974A JP 2006173246 A JP2006173246 A JP 2006173246A JP 2006173246 A JP2006173246 A JP 2006173246A JP 2008002974 A JP2008002974 A JP 2008002974A
- Authority
- JP
- Japan
- Prior art keywords
- covering
- substrate
- liquid
- active substance
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 20
- 239000000758 substrate Substances 0.000 claims abstract description 38
- 239000007788 liquid Substances 0.000 claims abstract description 25
- 239000013543 active substance Substances 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 16
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 16
- 239000007790 solid phase Substances 0.000 claims abstract description 10
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical group OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229920001577 copolymer Polymers 0.000 claims abstract description 5
- ZSZRUEAFVQITHH-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CC(=C)C(=O)OCCOP([O-])(=O)OCC[N+](C)(C)C ZSZRUEAFVQITHH-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000000178 monomer Substances 0.000 claims abstract description 4
- 238000000576 coating method Methods 0.000 claims description 23
- 239000011248 coating agent Substances 0.000 claims description 20
- 108020004707 nucleic acids Proteins 0.000 claims description 18
- 102000039446 nucleic acids Human genes 0.000 claims description 18
- 150000007523 nucleic acids Chemical class 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 18
- 229920000642 polymer Polymers 0.000 claims description 16
- 239000004033 plastic Substances 0.000 claims description 13
- 229920003023 plastic Polymers 0.000 claims description 13
- 125000006850 spacer group Chemical group 0.000 claims description 10
- 239000011521 glass Substances 0.000 claims description 7
- 239000004793 Polystyrene Substances 0.000 claims description 6
- 229920002223 polystyrene Polymers 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 108091023037 Aptamer Proteins 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108010038807 Oligopeptides Proteins 0.000 claims description 2
- 102000015636 Oligopeptides Human genes 0.000 claims description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 claims 1
- 239000012488 sample solution Substances 0.000 abstract description 31
- 238000002493 microarray Methods 0.000 abstract description 27
- 238000001179 sorption measurement Methods 0.000 abstract description 9
- 239000002861 polymer material Substances 0.000 abstract 2
- 238000011282 treatment Methods 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 13
- 238000009396 hybridization Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 8
- 238000007788 roughening Methods 0.000 description 8
- 239000000523 sample Substances 0.000 description 6
- 239000006059 cover glass Substances 0.000 description 5
- 238000001746 injection moulding Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000009832 plasma treatment Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000000018 DNA microarray Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000000748 compression moulding Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004049 embossing Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 2
- 238000010559 graft polymerization reaction Methods 0.000 description 2
- 238000010884 ion-beam technique Methods 0.000 description 2
- 238000013532 laser treatment Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000003746 surface roughness Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229920007962 Styrene Methyl Methacrylate Polymers 0.000 description 1
- 239000006061 abrasive grain Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003012 bilayer membrane Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 238000003851 corona treatment Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000005357 flat glass Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- ADFPJHOAARPYLP-UHFFFAOYSA-N methyl 2-methylprop-2-enoate;styrene Chemical compound COC(=O)C(C)=C.C=CC1=CC=CC=C1 ADFPJHOAARPYLP-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002285 poly(styrene-co-acrylonitrile) Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 150000003354 serine derivatives Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
Images
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
本発明は、固相基板上に試料溶液を接触させる際に、該溶液を基板上に保持する目的で使用する被覆体およびその使用方法に関する。 The present invention relates to a covering used for the purpose of holding a solution on a solid substrate when the sample solution is brought into contact with the substrate, and a method of using the same.
マイクロアレイは、固相基板表面に生理活性物質を固定化したデバイスである。例えば核酸マイクロアレイの場合、核酸がプラスチックやガラスなどの固相基板上に固定されている。核酸マイクロアレイの使用形態は、細胞などの検体から抽出、増幅した核酸を含む溶液をマイクロアレイ上に展開し、所定時間反応させる。マイクロアレイ上に固定された核酸と試料溶液中の核酸が、塩基配列の相同性に対応してハイブリダイゼーション反応を生じ、この反応率を蛍光色素や放射性同位体などの標識物によって定量化することにより、試料溶液に含まれる核酸の配列に関する情報を得ることができる。 The microarray is a device in which a physiologically active substance is immobilized on the surface of a solid phase substrate. For example, in the case of a nucleic acid microarray, the nucleic acid is fixed on a solid phase substrate such as plastic or glass. The nucleic acid microarray is used in such a manner that a solution containing nucleic acid extracted and amplified from a specimen such as a cell is developed on the microarray and reacted for a predetermined time. The nucleic acid immobilized on the microarray and the nucleic acid in the sample solution undergo a hybridization reaction corresponding to the homology of the base sequence, and this reaction rate is quantified by using a label such as a fluorescent dye or a radioisotope. Information on the sequence of the nucleic acid contained in the sample solution can be obtained.
一般的に生理活性物質の反応は液相反応であるため、マイクロアレイ上に固定された生理活性物質と試料を反応させるためには、試料を溶液状態でマイクロアレイ表面に接触させ、一定時間保持する必要がある。この操作では、試料溶液とマイクロアレイ表面が全面にわたって均一に接触することが重要となる。均一な接触とは、液層の厚みが一定であり、気泡などが含まれていないことである。また、反応中の試料溶液の蒸発を防ぐことも重要となる。試料溶液とマイクロアレイの接触が不均一であったり、試料溶液の一部が蒸発したりすると、マイクロアレイ上の位置によって反応効率に差異が生じてしまい、得られたデータの信頼性が低くなる。 Since the reaction of physiologically active substances is generally a liquid phase reaction, it is necessary to bring the sample into contact with the microarray surface in a solution state and hold it for a certain period of time in order to cause the sample to react with the physiologically active substance immobilized on the microarray. There is. In this operation, it is important that the sample solution and the microarray surface are uniformly contacted over the entire surface. Uniform contact means that the liquid layer has a constant thickness and does not contain bubbles. It is also important to prevent evaporation of the sample solution during the reaction. If the contact between the sample solution and the microarray is uneven or a part of the sample solution evaporates, the reaction efficiency varies depending on the position on the microarray, and the reliability of the obtained data is lowered.
被覆体としてはプレパラート作製用のカバーガラスを用いることが多い。液層の厚みを一定に保つためのスペーサーを設けたカバーガラスも使用されている。しかしながら、カバーガラスは薄いために非常に割れ易く、取り扱いが比較的煩雑なため、割れにくいプラスチック製の被覆体が注目されている(例えば特許文献1参照)。しかしながら、プラスチック表面は一般的に疎水性であることが多く、試料溶液との濡れ性が低いために溶液の均一な展開が困難である。すなわち、マイクロアレイ上に被覆体を被せ、間隙に試料溶液を流し込む際に、試料溶液が被覆体表面をスムーズに濡らすことができない。 As the covering, a cover glass for preparing a preparation is often used. A cover glass provided with a spacer for keeping the thickness of the liquid layer constant is also used. However, since the cover glass is thin, it is very easy to break, and handling is relatively complicated, and therefore, a plastic covering that is hard to break is attracting attention (see, for example, Patent Document 1). However, in general, the plastic surface is often hydrophobic, and the wettability with the sample solution is low, so that uniform development of the solution is difficult. That is, when the cover is placed on the microarray and the sample solution is poured into the gap, the sample solution cannot smoothly wet the surface of the cover.
また、マイクロアレイ上での生理活性物質の反応では、被覆体に用いるカバーガラスやスペーサーを設けたカバーガラスへの試料生理活性物質の非特異的な吸着も問題となっている。例えば、核酸マイクロアレイでは、試料核酸の被覆体への試料核酸の吸着が起こると、試料溶液中の核酸の絶対量が減少するために、基板に固定された核酸とのハイブリダイゼーションに影響を及ぼす。
被覆体への非特異的な吸着が激しいと、試料核酸中の濃度が変化してしまい、再現性がなく、信頼性に欠けるデータが得られることとなる。
このため、上述したような問題を解決することのできる被覆体、すなわち、試料溶液との濡れ性が高く、マイクロアレイ上への試料溶液の展開性を向上し、かつ、生理活性物質の吸着の少ない被覆体が求められていた。
Further, in the reaction of the physiologically active substance on the microarray, nonspecific adsorption of the sample physiologically active substance to the cover glass used for the covering or the cover glass provided with the spacer is also a problem. For example, in the nucleic acid microarray, when the sample nucleic acid is adsorbed to the coating of the sample nucleic acid, the absolute amount of the nucleic acid in the sample solution is decreased, thereby affecting the hybridization with the nucleic acid immobilized on the substrate.
If non-specific adsorption to the covering is intense, the concentration in the sample nucleic acid changes, resulting in data that is not reproducible and lacks reliability.
For this reason, the covering which can solve the above-mentioned problems, that is, the wettability with the sample solution is high, the spreadability of the sample solution on the microarray is improved, and the adsorption of the physiologically active substance is small. A coating was sought.
本発明は、固相基板上に試料溶液を接触させる際に用いる被覆体であり、試料溶液の展開性を向上させ、かつ試料溶液中の生理活性物質の吸着を低減した被覆体を提供することを目的とする。 The present invention provides a covering used for bringing a sample solution into contact with a solid phase substrate, improving the developability of the sample solution, and reducing the adsorption of a physiologically active substance in the sample solution. With the goal.
本発明は、
(1)固相基板上に液体を保持する際に基板上に設置する被覆体であって、少なくとも被覆体の液体と接触する側の面がリン脂質を有する物質でコーティングされていることを特徴とする被覆体、
(2)前記リン脂質を有する物質が、ホスホリルコリン基を有する高分子物質である(1)記載の被覆体、
(3) 前記ホスホリルコリン基を有する高分子物質が、2−メタクリロイルオキシエチルホスホリルコリンをモノマー単位として含む共重合体である(2)記載の被覆体、
(4)固相基板上に液体を保持する際に液層の厚みを一定に保持する手段として、スペーサーが設けてある(1)〜(3)いずれか記載の被覆体、
(5)前記被覆体の液体と接触する側の面が、中心線平均粗さ(Ra値)が0.001〜10μmの粗面である(1)〜(4)いずれか記載の被覆体、
(6)前記被覆体の液体と接触する側の面に、溝の幅及び深さが0.1〜500μmである微細な溝状構造を設けたことを(1)〜(5)いずれか記載の被覆体、
(7)前記被覆体の素材がプラスチックである(1)〜(6)いずれか記載の被覆体、
(8)前記プラスチックがポリスチレンである(7)記載の被覆体、
(9)前記被覆体の素材がガラスである(1)〜(6)いずれか記載の被覆体、
(10)第一の生理活性物質が固定化されている基板表面に第二の生理活性物質を含む液体を接触させる際に、(1)〜(9)いずれか記載の被覆体を用いて前記液体を前記基板上に保持することを特徴とする被覆体の使用方法、
(11)第一の生理活性物質が固定化されている基板表面に(1)〜(9)いずれか記載の被覆体を前記基板表面に被せたのちに、前記基板と前記被覆体との間隙に第二の生理活性物質を含む液体を流入させることを特徴とする被覆体の使用方法、
(12)前記生理活性物質が核酸、ペプチド核酸、アプタマー、オリゴペプチド、タンパク質、酵素、糖鎖、およびそれらの誘導体の中から選ばれる少なくとも1つであるか、又はこれらの中から少なくとも1つを含む複合体である(11)又は(12)記載の被覆体の使用方法、
である。
The present invention
(1) A covering that is placed on a substrate when the liquid is held on the solid phase substrate, and at least a surface of the covering that is in contact with the liquid is coated with a substance having phospholipid. A covering,
(2) The covering according to (1), wherein the substance having phospholipid is a polymer substance having a phosphorylcholine group,
(3) The covering according to (2), wherein the polymer substance having a phosphorylcholine group is a copolymer containing 2-methacryloyloxyethyl phosphorylcholine as a monomer unit,
(4) The covering according to any one of (1) to (3), wherein a spacer is provided as a means for keeping the thickness of the liquid layer constant when holding the liquid on the solid phase substrate,
(5) The covering according to any one of (1) to (4), wherein the surface of the covering that is in contact with the liquid is a rough surface having a center line average roughness (Ra value) of 0.001 to 10 μm.
(6) Any one of (1) to (5), wherein a fine groove-like structure having a groove width and depth of 0.1 to 500 μm is provided on a surface of the covering body that contacts the liquid. Coverings,
(7) The covering according to any one of (1) to (6), wherein the material of the covering is plastic.
(8) The covering according to (7), wherein the plastic is polystyrene,
(9) The covering according to any one of (1) to (6), wherein the material of the covering is glass,
(10) When the liquid containing the second physiologically active substance is brought into contact with the substrate surface on which the first physiologically active substance is immobilized, the covering according to any one of (1) to (9) is used. A method of using a covering, characterized by holding a liquid on the substrate;
(11) After covering the surface of the substrate on which the first physiologically active substance is immobilized with the cover according to any one of (1) to (9), the gap between the substrate and the cover A method of using a covering, wherein a liquid containing a second physiologically active substance is allowed to flow into
(12) The physiologically active substance is at least one selected from nucleic acids, peptide nucleic acids, aptamers, oligopeptides, proteins, enzymes, sugar chains, and derivatives thereof, or at least one of these A method for using the covering according to (11) or (12), which is a composite comprising:
It is.
本発明により、固相基板上に試料溶液を接触させる際に、試料溶液の展開性を向上させ、かつ試料溶液中の生理活性物質の吸着を低減した被覆体が得られ、特にマイクロアレイを用いた場合の評価の信頼性向上が可能となった。 According to the present invention, when a sample solution is brought into contact with a solid phase substrate, a coating body that improves the developability of the sample solution and reduces the adsorption of a physiologically active substance in the sample solution can be obtained, particularly using a microarray. It has become possible to improve the reliability of the evaluation.
以下、本発明を詳細に説明する。
核酸マイクロアレイを用いた遺伝子解析、遺伝子同定などの評価における信頼性を左右する要素として、ハイブリダイゼーション反応の均一性が挙げられる。ハイブリダイゼーション反応を均一に行なうためには、マイクロアレイ表面と試料溶液との接触が、アレイ全面にわたって均一であることが重要である。すなわち、試料溶液の厚みが一定であること、反応中に試料溶液が乾燥しないこと、試料溶液層に気泡が混入しないことが重要である。
Hereinafter, the present invention will be described in detail.
The uniformity of the hybridization reaction can be cited as an element that influences reliability in evaluations such as gene analysis and gene identification using a nucleic acid microarray. In order to perform the hybridization reaction uniformly, it is important that the contact between the microarray surface and the sample solution is uniform over the entire surface of the array. That is, it is important that the thickness of the sample solution is constant, that the sample solution is not dried during the reaction, and that no bubbles are mixed into the sample solution layer.
本発明は、固相基板上に液体を保持する際に基板上に設置する被覆体であって、少なくとも被覆体の液体と接触する側の面がリン脂質を有する物質でコーティングされている被覆体である。 The present invention relates to a covering that is placed on a substrate when a liquid is held on a solid-phase substrate, and at least the surface of the covering that comes into contact with the liquid is coated with a substance having a phospholipid. It is.
リン脂質を有する物質とは、リン酸と脂質が結合したものの総称であって、おもに細胞の表面にあって細胞膜を構成する役割を担っている。本発明では、グリセロール誘導体であるホスファチジルエタノールアミン、ホスファチジルセリン、ホスファチジルコリンやセリン誘導体であるスフィンゴエミリンなどを好適に用いることができる。 The substance having phospholipid is a general term for a combination of phosphoric acid and lipid, and is mainly on the surface of a cell and plays a role of constituting a cell membrane. In the present invention, glycerol derivatives such as phosphatidylethanolamine, phosphatidylserine, phosphatidylcholine, and serine derivatives such as sphingoemilin can be preferably used.
本発明では、リン脂質を有する物質としてホスホリルコリン基を含む高分子物質を用いることが好ましい。ホスホリルコリン基を含む高分子物質として、2−メタクリロイルオキシエチルホスホリルコリンをモノマー単位とする共重合体(MPCポリマー)を好適に用いることができる。MPCポリマーはリン脂質二重層膜と類似の構造を有し、生理活性物質の吸着を抑制する効果を有することや生理活性分子を安定化することが知られている(Ishihara K, Tsuji T, Kurosaki T, Nakabayashi N, Journal of Biomedical Materials Research, 28(2), pp.225-232, (1994) などを参照)。 In the present invention, a polymer substance containing a phosphorylcholine group is preferably used as the substance having a phospholipid. As a polymer substance containing a phosphorylcholine group, a copolymer (MPC polymer) having 2-methacryloyloxyethyl phosphorylcholine as a monomer unit can be suitably used. MPC polymers have a structure similar to that of phospholipid bilayer membranes, and are known to have the effect of suppressing the adsorption of bioactive substances and to stabilize bioactive molecules (Ishihara K, Tsuji T, Kurosaki T, Nakabayashi N, Journal of Biomedical Materials Research, 28 (2), pp.225-232, (1994)).
MPCポリマー層を被覆体表面に形成する方法としては、ディップコート法を用いることができる。すなわち、MPCポリマー溶液に基板を浸漬した後、溶媒を揮発させることにより表面にMPCポリマー層を形成する。MPCポリマーの濃度は、0.01〜10重量%が好ましく、0.01〜5重量%がより好ましく、0.1〜5重量%がさらに好ましい。 As a method for forming the MPC polymer layer on the surface of the covering, a dip coating method can be used. That is, after the substrate is immersed in the MPC polymer solution, the MPC polymer layer is formed on the surface by volatilizing the solvent. The concentration of the MPC polymer is preferably 0.01 to 10% by weight, more preferably 0.01 to 5% by weight, and still more preferably 0.1 to 5% by weight.
(被覆体の素材)
本発明で用いることのできる被覆体の素材として、ガラスやプラスチックが挙げられる。プラスチックの素材としては、ハイブリダイゼーション反応時の温度で変形せず、溶媒や緩衝液に耐性があり、吸水性が低いものが好ましい。また、試料溶液の厚みを一定に保つため、素材は自重で変形しない程度の剛性を有することが好ましい。さらに、試料溶液をマイクロアレイ上に展開する際に、溶液の状態を目視で確認可能なことが好ましく、被覆体の素材は透明あるいは半透明であることが好ましい。これらの条件を満たす素材として、ポリスチレン、環状ポリオレフィン、ポリカーボネート、ポリプロピレン、ポリメタクリル酸メチル、スチレン−メタクリル酸メチル共重合体、スチレン−アクリロニトリル共重合体、ポリ−4−メチルペンテン−1などを用いることができるが、ポリスチレン、環状ポリオレフィン、ポリカーボネート、又はポリプロピレンであることが好ましい。
(Cover body material)
Examples of the covering material that can be used in the present invention include glass and plastic. The plastic material is preferably one that does not deform at the temperature during the hybridization reaction, is resistant to solvents and buffers, and has low water absorption. Further, in order to keep the thickness of the sample solution constant, it is preferable that the material has rigidity enough to prevent deformation due to its own weight. Furthermore, it is preferable that the state of the solution can be visually confirmed when the sample solution is developed on the microarray, and the covering material is preferably transparent or translucent. As materials satisfying these conditions, polystyrene, cyclic polyolefin, polycarbonate, polypropylene, polymethyl methacrylate, styrene-methyl methacrylate copolymer, styrene-acrylonitrile copolymer, poly-4-methylpentene-1 and the like are used. However, it is preferably polystyrene, cyclic polyolefin, polycarbonate, or polypropylene.
(被覆体の親水化)
また、マイクロアレイ上に被覆体を被せ、間隙に試料溶液を流し込む際に、試料溶液を被覆体表面にスムーズに濡らすために、プラスチック製の濡れ性を向上させる手段をとることもできる。プラスチック表面の濡れ性を向上させる手段としては、酸化処理であることが好ましい。酸化処理としては、プラズマ処理、コロナ放電処理、紫外線照射、火炎処理、薬剤処理などの方法を用いることが好ましく、プラズマ処理であることが最も好ましい。
(Hydrophilic coating)
In addition, when covering the microarray with the covering and pouring the sample solution into the gap, means for improving the wettability made of plastic can be taken in order to smoothly wet the sample solution onto the surface of the covering. As means for improving the wettability of the plastic surface, an oxidation treatment is preferable. As the oxidation treatment, methods such as plasma treatment, corona discharge treatment, ultraviolet irradiation, flame treatment, and chemical treatment are preferably used, and plasma treatment is most preferred.
(表面の粗面化)
プラスチック表面を粗面化することにより、液体との濡れ性をコントロールすることができる。表面を粗面化する方法は乾式法と湿式法に大別される。乾式法として、機械的な粗面化、プラズマ接触処理、イオンビーム処理、エキシマレーザー処理等を利用することができる。機械的な粗面化とは、物理的な力を付加して表面に微小な凹凸を付与する方法である。具体的には、金型形状の転写、砥粒等による研磨、サンドペーパーや布などによるスクラッチング、粒子の吹き付けなどを利用することができる。表面の粗さを高度に制御する必要がある場合、プラズマ接触処理、イオンビーム処理、エキシマレーザー処理等を利用することができる。湿式法には、薬剤処理、溶剤処理等がある。具体的には、酸、アルカリ、材料の良溶媒を用いた処理で表面の一部を溶解させ、粗面化を実現することができる。上述の粗面化法のうち、製造の容易性の観点から、機械的な粗面化が好ましい。その中でも、金型形状の転写による方法がより好ましい。金型の形状を転写する手段として、射出成形、圧縮成形、押出成形、エンボス加工等を利用することができる。
(Surface roughening)
By roughening the plastic surface, the wettability with the liquid can be controlled. The method of roughening the surface is roughly divided into a dry method and a wet method. As the dry method, mechanical surface roughening, plasma contact treatment, ion beam treatment, excimer laser treatment, or the like can be used. Mechanical roughening is a method of imparting microscopic irregularities to the surface by applying a physical force. Specifically, mold shape transfer, polishing with abrasive grains, scratching with sandpaper or cloth, and spraying of particles can be used. When it is necessary to highly control the surface roughness, plasma contact treatment, ion beam treatment, excimer laser treatment, or the like can be used. Examples of the wet method include chemical treatment and solvent treatment. Specifically, roughening can be realized by dissolving a part of the surface by treatment with a good solvent of acid, alkali, or material. Of the above roughening methods, mechanical roughening is preferred from the viewpoint of ease of production. Among them, a method by transferring a mold shape is more preferable. As means for transferring the shape of the mold, injection molding, compression molding, extrusion molding, embossing or the like can be used.
粗面化した被覆体の表面粗さは、中心線平均粗さ(Ra値)が0.001〜10μmであることが好ましく、0.005〜1μmであることがより好ましく、は0.05〜0.1μmであることがさらに好ましい。上記のような手段で粗面化を施した被覆体表面に対して、さらに酸化処理、グラフト重合、コーティングなどの親水化処理を施すことも可能である。 As for the surface roughness of the roughened covering, the center line average roughness (Ra value) is preferably 0.001 to 10 μm, more preferably 0.005 to 1 μm, and more preferably 0.05 to More preferably, it is 0.1 μm. It is also possible to perform a hydrophilization treatment such as oxidation treatment, graft polymerization, coating, etc., on the surface of the coated body which has been roughened by the above means.
(表面の微細加工)
プラスチック表面に微細な溝を設けることにより、試料溶液との濡れ性を高めることができる。微細な溝を設ける方法として、射出成形、圧縮成形、押出成形、エンボス加工等による金型形状の転写、切削加工、レーザー加工、リソグラフィなどの方法を利用することができる。製造の容易性の観点から、金型形状の転写が好ましい。
(Surface fine processing)
By providing fine grooves on the plastic surface, wettability with the sample solution can be enhanced. As a method for providing a fine groove, a method such as injection molding, compression molding, extrusion molding, embossing, or the like can be used, such as mold shape transfer, cutting, laser processing, or lithography. From the viewpoint of ease of production, transfer of the mold shape is preferred.
溝の幅および深さは、0.1〜500μmが好ましく、1〜200μmがより好ましく、10〜200μmがさらに好ましい。
微細な溝を設けた被覆体表面に対して、さらに酸化処理、グラフト重合、コーティングなどの親水化処理を施すことも可能である。
The width and depth of the groove are preferably 0.1 to 500 μm, more preferably 1 to 200 μm, and still more preferably 10 to 200 μm.
It is also possible to subject the surface of the coated body provided with fine grooves to a hydrophilic treatment such as oxidation treatment, graft polymerization, and coating.
(被覆体の形状)
マイクロアレイ基板が平面である場合、試料溶液の厚みを一定に保つため、被覆体の形状は平面であることが好ましい。さらに、被覆体表面とマイクロアレイ表面との間隙を一定に保つため、図1〜3に示すように被覆体の周縁部あるいはその一部にスペーサー部(肉厚部)を設けることが好ましい。
(Shape of covering)
When the microarray substrate is flat, the shape of the covering is preferably flat in order to keep the thickness of the sample solution constant. Further, in order to keep the gap between the surface of the covering and the surface of the microarray constant, it is preferable to provide a spacer portion (thickness portion) at the peripheral portion of the covering or a part thereof as shown in FIGS.
スペーサーの厚み(被覆体とマイクロアレイの間隙)は、5〜100μmが好ましく、5〜50μmがより好ましく、10〜30μmが最も好ましい。 The spacer thickness (gap between the covering and the microarray) is preferably 5 to 100 μm, more preferably 5 to 50 μm, and most preferably 10 to 30 μm.
以下の実施例により本発明を具体的に説明するが、本発明は、実施例の範囲に限定されるものではない。 The present invention is specifically described by the following examples, but the present invention is not limited to the scope of the examples.
(実施例1)
ポリスチレンを材料として、射出成形法により被覆体を作製した。被覆体の形状は長方形の平滑な板状(60mm×25mm×0.7mm)であり、図1のように長辺側の縁に下駄の歯状のスペーサー部(60mm×1mm×20μm)設けたものであった。得られた射出成形品をリン脂質・ポリマー複合体(MPC(2−メタクリロイルホスホリルコリン)/BMA(ブチルメタクリレート)モル比=3/7の共重合体)の0.5重量%エタノール溶液に室温で10分間浸漬した後に引き上げ、室温で一晩乾燥させてリン脂質・ポリマー複合体を表面にコーティングした被覆体を得た。
(Example 1)
Using polystyrene as a material, a covering was produced by an injection molding method. The shape of the covering is a rectangular smooth plate (60 mm × 25 mm × 0.7 mm), and a clogged tooth-like spacer (60 mm × 1 mm × 20 μm) is provided on the edge of the long side as shown in FIG. It was a thing. The obtained injection-molded article was added to a 0.5 wt% ethanol solution of a phospholipid / polymer composite (MPC (2-methacryloylphosphorylcholine) / BMA (butyl methacrylate) molar ratio = 3/7 copolymer) at room temperature. After being immersed for a minute, it was pulled up and dried overnight at room temperature to obtain a coated body having a surface coated with a phospholipid / polymer complex.
(実施例2)
ポリスチレンを材料として、射出成形法により被覆体を作製した。被覆体の形状は長方形の平滑な板状(60mm×25mm×0.7mm)であり、図1のように長辺側の縁に下駄の歯状のスペーサー部(60mm×1mm×20μm)を設けたものであった。得られた射出成形品をプラズマ処理することにより被覆体表面を親水化した後に、リン脂質・ポリマー複合体(MPC(2−メタクリロイルホスホリルコリン)/BMA(ブチルメタクリレート)モル比=3/7の共重合体)の0.5重量%エタノール溶液に室温で10分間浸漬した後に引き上げ、室温で一晩乾燥させてリン脂質・ポリマー複合体を表面にコーティングした被覆体を得た。
(Example 2)
Using polystyrene as a material, a covering was produced by an injection molding method. The shape of the cover is a rectangular smooth plate (60 mm x 25 mm x 0.7 mm), and a clogged tooth-like spacer (60 mm x 1 mm x 20 µm) is provided on the long side edge as shown in Fig. 1. It was. The obtained injection-molded product is subjected to plasma treatment to make the surface of the coated body hydrophilic, and then a phospholipid / polymer composite (MPC (2-methacryloylphosphorylcholine) / BMA (butyl methacrylate) molar ratio = 3/7 co-weight). After being soaked in a 0.5 wt% ethanol solution of coalescence) at room temperature for 10 minutes, it was pulled up and dried overnight at room temperature to obtain a coated body having a surface coated with a phospholipid / polymer complex.
(実施例3)
実施例1と同様の形状のガラス品を用意した。実施例1と同様のコーティング方法で被覆体を作製した。
(Example 3)
A glass product having the same shape as in Example 1 was prepared. A covering was produced by the same coating method as in Example 1.
(比較例1)
実施例1と同様の形状の被覆体を射出成形法により作製し、コーティングせずにそのまま用いた。
(Comparative Example 1)
A coated body having the same shape as in Example 1 was produced by an injection molding method and used as it was without coating.
(比較例2)
市販のガラス製被覆体を入手し、そのまま用いた。ガラス製被覆体の形状は、平板状のガラスの四隅にスペーサーが設置されたものであった。
(Comparative Example 2)
A commercially available glass coating was obtained and used as it was. The shape of the glass covering was such that spacers were installed at the four corners of the flat glass.
(評価1)
実施例1〜3、及び比較例1〜2の被覆体表面の水との接触角を測定した。結果を表1に示す。
(Evaluation 1)
The contact angle with the water of the coating body surface of Examples 1-3 and Comparative Examples 1-2 was measured. The results are shown in Table 1.
(評価2)
実施例、及び比較例の被覆体を表面がアルデヒド処理されたマイクロアレイ用基板(75mm×25mm×1.0mm)の表面上に設置し、基板と被覆体の間隙に、ピペットを用いてハイブリダイゼーション反応用緩衝液(0.3M塩化ナトリウム、0.03Mクエン酸3ナトリウム、0.2%ドデシル硫酸ナトリウム水溶液)を流し込んだ。緩衝液の展開性、および、被覆体と基板との間の気泡の混入の有無を目視により評価した。結果を表1に示す。
(Evaluation 2)
The coatings of Examples and Comparative Examples were placed on the surface of a microarray substrate (75 mm × 25 mm × 1.0 mm) whose surface was treated with aldehyde, and a hybridization reaction was performed using a pipette in the gap between the substrate and the coating. Buffer solution (0.3 M sodium chloride, 0.03 M trisodium citrate, 0.2% aqueous sodium dodecyl sulfate) was poured. The developability of the buffer solution and the presence or absence of air bubbles between the coating and the substrate were visually evaluated. The results are shown in Table 1.
(評価3:被覆体の非特異的吸着性)
実施例、及び比較例の被覆体を、Streptavidin−Cy3(アマシャムバイオサイエンス(株)PA43001)の原液を1000倍希釈したリン酸バッファー(pH7.4)中に浸漬し、37℃で30分浸漬した。リン酸バッファーで洗浄後、乾燥した。
上記操作により得られた被覆体を、マイクロアレイ用スキャナ「ScanArray Lite」(パッカードバイオチップテクノロジー社製)を用いて、各基板の蛍光を検出した。このときの測定条件は、レーザー出力90%、PMT感度60%、励起波長550nm、測定波長570nm、解像度50μmであった。
蛍光強度の数値化は、スキャナに付属の解析用ソフトウェア「QuantArray」を用いて行なった。結果を表2に示す。
(Evaluation 3: Non-specific adsorption of the coating)
The coated bodies of Examples and Comparative Examples were immersed in a phosphate buffer (pH 7.4) obtained by diluting a stock solution of Streptavidin-Cy3 (Amersham Biosciences Corp. PA43001) 1000 times and immersed at 37 ° C. for 30 minutes. . After washing with phosphate buffer, it was dried.
Using the microarray scanner “ScanArray Lite” (manufactured by Packard Biochip Technology), the fluorescence of each substrate was detected from the covering obtained by the above operation. The measurement conditions at this time were laser output 90%, PMT sensitivity 60%, excitation wavelength 550 nm, measurement wavelength 570 nm, and resolution 50 μm.
Quantification of fluorescence intensity was performed using analysis software “QuantArray” attached to the scanner. The results are shown in Table 2.
(評価4:被覆体を用いたハイブリダイゼーション)
表面がアルデヒド処理されたマイクロアレイ用基板(75mm×25mm×1.0mm)表面に、末端にアミノ基を導入した鎖長50bpのオリゴヌクレオチド(atagaagttt gtccatttgt aaactcccgg attgcgctcc ctcccgcctt(配列番号1))の水溶液(10μM)を点着した。80℃で1時間熱処理を施したのち、純水で洗浄し、ブロッキング処理を行なった。次いで純水で洗浄し、遠心することにより水滴を除去した。
この基板に実施例、及び比較例の被覆体を基板上に被せ、注入口(基板と被覆体の隙間)から、ハイブリダイゼーション溶液を注入した。ハイブリダイゼーション溶液は、5’末端にCy3を導入した鎖長50bpのオリゴDNA(AAGGCGGGAGGGAGCGCAATCCGGGAGTTTACAAATGGACAAACTTCTAT(配列番号2))を5×SSC、0.3%SDSの緩衝液に溶かした溶液で行なった。ハイブリダイゼーション反応は、65℃で3時間行なった。ハイブリダイゼーション終了後、2×SSC、0.1%SDS中で、10分浸漬した。その後、0.2×SSC、0.02×SSCの順に洗浄を行なった。次いで、基板を遠心することにより乾燥した。
上記操作により得られた基板を、マイクロアレイ用スキャナ「ScanArray Lite」(パッカードバイオチップテクノロジー社製)を用いて、各基板のスポットの蛍光を検出した。このときの測定条件は、レーザー出力90%、PMT感度60%、励起波長550nm、測定波長570nm、解像度50μmであった。
スポットの蛍光強度の数値化は、スキャナに付属の解析用ソフトウェア「QuantArray」を用いて行なった。実施例、比較例で得られた蛍光値、CV値を表3に示す。CV値は、96スポットの各蛍光値の平均値を96スポットの各蛍光値の標準偏差で除した値であり、シグナルのバラツキを表すものである。
(Evaluation 4: Hybridization using a covering)
An aqueous solution (10 μM) of an oligonucleotide (atagaagttt gtccatttgt aaactcccgg attgcgctcc ctcccgcctt (SEQ ID NO: 1)) having an amino group introduced at the end thereof on the surface of an aldehyde-treated microarray substrate (75 mm × 25 mm × 1.0 mm) ). After heat treatment at 80 ° C. for 1 hour, it was washed with pure water and subjected to blocking treatment. Subsequently, it was washed with pure water and centrifuged to remove water droplets.
The substrates of Examples and Comparative Examples were placed on the substrate, and the hybridization solution was injected from the injection port (gap between the substrate and the cover). The hybridization solution was a solution in which a 50 bp long oligo DNA (AAGGCGGGAGGGAGCGCAATCCGGGAGTTTACAAATGGACAAACTTCTAT (SEQ ID NO: 2)) having Cy3 introduced at the 5 ′ end was dissolved in 5 × SSC, 0.3% SDS buffer. The hybridization reaction was performed at 65 ° C. for 3 hours. After completion of hybridization, the cells were immersed in 2 × SSC and 0.1% SDS for 10 minutes. Thereafter, washing was performed in the order of 0.2 × SSC and 0.02 × SSC. The substrate was then dried by centrifuging.
Using the microarray scanner “ScanArray Lite” (manufactured by Packard Biochip Technology), the fluorescence of the spot on each substrate was detected from the substrate obtained by the above operation. The measurement conditions at this time were laser output 90%, PMT sensitivity 60%, excitation wavelength 550 nm, measurement wavelength 570 nm, and resolution 50 μm.
Quantification of the fluorescence intensity of the spot was performed using analysis software “QuantArray” attached to the scanner. Table 3 shows the fluorescence values and CV values obtained in Examples and Comparative Examples. The CV value is a value obtained by dividing the average value of each fluorescence value of 96 spots by the standard deviation of each fluorescence value of 96 spots, and represents a variation in signal.
評価1、2の結果において、本発明におけるコーティング方法が濡れ性向上に有効であることが示された。
評価3の結果において、実施例1〜3では、比較例1〜2と比較して、蛍光シグナル値が大幅に低くなった。これは、実施例1〜3におけるリン脂質を有する物質でコーティングした被覆体が非特異的吸着を抑制していることを支持する結果であった。
評価4では、実施例1〜3では、比較例1〜2と比較して、蛍光シグナル値が高い結果となった。これは、実施例1〜3におけるリン脂質を有する物質でコーティングした被覆体に吸着する核酸が抑制されたことにより、ハイブリダイゼーション溶液中の核酸濃度が上昇したことによる結果であると考えられ、これは本発明の効果を支持するものであった。
In the results of
In the result of Evaluation 3, in Examples 1 to 3, the fluorescence signal value was significantly reduced as compared with Comparative Examples 1 and 2. This was a result supporting that the coating body coated with the substance having a phospholipid in Examples 1 to 3 suppressed nonspecific adsorption.
In Evaluation 4, in Examples 1 to 3, the fluorescence signal value was higher than in Comparative Examples 1 and 2. This is considered to be a result of the increase in the nucleic acid concentration in the hybridization solution due to the suppression of the nucleic acid adsorbed on the coating coated with the phospholipid-containing substance in Examples 1 to 3, This supported the effect of the present invention.
1:平面部
2:肉厚部(スペーサー)、斜線で表示
1: Plane part 2: Thick part (spacer), indicated by diagonal lines
Claims (12)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006173246A JP2008002974A (en) | 2006-06-23 | 2006-06-23 | Covering body and using method of covering body |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006173246A JP2008002974A (en) | 2006-06-23 | 2006-06-23 | Covering body and using method of covering body |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2008002974A true JP2008002974A (en) | 2008-01-10 |
Family
ID=39007481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006173246A Pending JP2008002974A (en) | 2006-06-23 | 2006-06-23 | Covering body and using method of covering body |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2008002974A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013215109A (en) * | 2012-04-05 | 2013-10-24 | Seiko Epson Corp | Separator |
| JP2014190694A (en) * | 2013-03-26 | 2014-10-06 | Dainippon Printing Co Ltd | Method for measuring anti-allergenic performance |
| JP2015001394A (en) * | 2013-06-13 | 2015-01-05 | 住友ベークライト株式会社 | Cover body and use of the same |
| WO2019050017A1 (en) * | 2017-09-07 | 2019-03-14 | 三菱瓦斯化学株式会社 | Substrate for biochip, biochip, method for manufacturing biochip, and method for preserving biochip |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006084393A (en) * | 2004-09-17 | 2006-03-30 | Sumitomo Bakelite Co Ltd | Biochip |
-
2006
- 2006-06-23 JP JP2006173246A patent/JP2008002974A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006084393A (en) * | 2004-09-17 | 2006-03-30 | Sumitomo Bakelite Co Ltd | Biochip |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013215109A (en) * | 2012-04-05 | 2013-10-24 | Seiko Epson Corp | Separator |
| JP2014190694A (en) * | 2013-03-26 | 2014-10-06 | Dainippon Printing Co Ltd | Method for measuring anti-allergenic performance |
| JP2015001394A (en) * | 2013-06-13 | 2015-01-05 | 住友ベークライト株式会社 | Cover body and use of the same |
| WO2019050017A1 (en) * | 2017-09-07 | 2019-03-14 | 三菱瓦斯化学株式会社 | Substrate for biochip, biochip, method for manufacturing biochip, and method for preserving biochip |
| JPWO2019050017A1 (en) * | 2017-09-07 | 2020-10-22 | 三菱瓦斯化学株式会社 | Biochip substrate, biochip, biochip manufacturing method and storage method |
| JP7700430B2 (en) | 2017-09-07 | 2025-07-01 | 三菱瓦斯化学株式会社 | Substrate for biochip, biochip, method for producing biochip and method for storing same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12163180B2 (en) | Patterned flow-cells useful for nucleic acid analysis | |
| US7682816B2 (en) | Thin film coated microwell arrays and methods of using same | |
| US7785862B2 (en) | Thin film coated microwell arrays | |
| JP2023058485A (en) | gel patterned surface | |
| CN108603223B (en) | Three-dimensional polymer network having channels located therein | |
| US6913931B2 (en) | Devices, methods and systems for low volume microarray processing | |
| US8795787B2 (en) | Surface modification | |
| TWI795409B (en) | Three-dimensional polymer networks and their use | |
| JP2004502949A (en) | Improved conjugate of microporous membrane and solid support for microanalytical diagnostic applications | |
| JP2010008391A (en) | Chip for analysis | |
| JP2008002974A (en) | Covering body and using method of covering body | |
| WO2008028011A2 (en) | Compositions and methods for preserving permeation layers for use on active electronic matrix devices | |
| WO2005095961A1 (en) | Process for producing biochip, probe solution, and biochip | |
| Vlachopoulou et al. | Protein arrays on high-surface-area plasma-nanotextured poly (dimethylsiloxane)-coated glass slides | |
| Soto et al. | Immobilization and hybridization of DNA in a sugar polyacrylate hydrogel | |
| WO2015033668A1 (en) | Biochip substrate | |
| Shishkin et al. | Development of biological microchips on an aluminum support with cells made of brush polymers | |
| JP2003107086A (en) | Nucleic acid probe array using substrate with frosting surface | |
| JP2010210308A (en) | Substrate for microarray and microarray | |
| JP4761241B2 (en) | Biomolecule interaction test apparatus, biomolecule interaction test method, biomolecule melting temperature measurement method, nucleic acid sequence detection method | |
| GR1009057B (en) | Method to fabricate chemically-stable plasma-etched substrates for direct covalent biomolecule immobilization | |
| US20060166285A1 (en) | Charged permeation layers for use on active electronic matrix devices | |
| Arrabito et al. | Imbibition of fL-scale DNA-rich aqueous droplets into Porous Nylon Substrates by Molecular Printing | |
| WO2005063412A1 (en) | Method for coating a surface |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20081110 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100929 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101005 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101203 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110419 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110830 |